JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B4923 TA 01

Summary: CK1ε, CK1δ,and p38α inhibitor

insoluble in H2O; insoluble in EtOH; ≥12.75 mg/mL
B4924 TA 02

Summary: p38 MAPK inhibitor

insoluble in H2O; ≥12.65 mg/mL
B4925 C34

Summary: TLR4 inhibitor

Soluble in DMSO
B4936 CKI 7 dihydrochloride
1 Citation

Summary: Casein kinase 1 (CK1) inhibitor

<17.93 mg/mL
A8709 SW033291

Target: 15-PGDH

Summary: 15-PGDH enzyme inhibitor
B5833 GSK503
2 Citation

Summary: EZH2 inhibitor

≥21.65 mg/mL
B5837 SAG

Summary: Hh and Smo agonist

≥24.5 mg/mL
B5977 Windorphen

Summary: Wnt inhibitor

insoluble in EtOH; insoluble in H2O; ≥11.45 mg/mL
B5979 CCT251545

Summary: Orally bioavailable and potent WNT signaling inhibitor

≥42.2 mg/mL
A8719 ML 239

Summary: inhibitor of the breast cancer stem cells

Soluble in DMSO